Back to NTLA

Intellia Therapeutics, Inc. 8-K

Accession 0001193125-26-084309

Filing information

CIK
0001652130
Report date
2026-03-02
Filing date
2026-03-02
Form
8-K
Primary document
d101756d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.